tiprankstipranks
Advertisement
Advertisement

PCLYFEG Stock Latest News

Lyfegen – Weekly Recap
Private CompaniesLyfegen – Weekly Recap
2d ago
LYFEG
Lyfegen Targets PLA Management Opportunities at Canada’s Drug Agency Symposium
PremiumPrivate Companies
Lyfegen Targets PLA Management Opportunities at Canada’s Drug Agency Symposium
3d ago
LYFEG
Lyfegen Targets Canadian Market Access Stakeholders at National Drug Agency Symposium
PremiumPrivate Companies
Lyfegen Targets Canadian Market Access Stakeholders at National Drug Agency Symposium
4d ago
LYFEG
Lyfegen Sharpens Focus on MFN Drug Pricing and Market Access Ahead of 2026 Basel Forums
PremiumPrivate Companies
Lyfegen Sharpens Focus on MFN Drug Pricing and Market Access Ahead of 2026 Basel Forums
9d ago
LYFEG
Lyfegen Targets Market Access Visibility at 2026 Basel Pricing and Payer Forums
PremiumPrivate Companies
Lyfegen Targets Market Access Visibility at 2026 Basel Pricing and Payer Forums
12d ago
LYFEG
Lyfegen Highlights MFN Drug Pricing Impact on Global Launch Strategies
PremiumPrivate CompaniesLyfegen Highlights MFN Drug Pricing Impact on Global Launch Strategies
12d ago
LYFEG
Lyfegen Examines MFN Drug Pricing Impact on Global Launch and Access Strategies
Premium
Private Companies
Lyfegen Examines MFN Drug Pricing Impact on Global Launch and Access Strategies
13d ago
LYFEG
MFN Drug Pricing Pressures Disrupt Global Launch Strategies and Patient Access
Premium
Private Companies
MFN Drug Pricing Pressures Disrupt Global Launch Strategies and Patient Access
18d ago
LYFEG
MFN Drug Pricing Pressures Highlighted as Launch Delays and Market Exits Mount
PremiumPrivate Companies
MFN Drug Pricing Pressures Highlighted as Launch Delays and Market Exits Mount
19d ago
LYFEG
Lyfegen Targets Pharma Contracting as Strategic Market Access Opportunity
PremiumPrivate Companies
Lyfegen Targets Pharma Contracting as Strategic Market Access Opportunity
19d ago
LYFEG
Lyfegen Targets Strategic Pharma Contracting and Market Access
PremiumPrivate Companies
Lyfegen Targets Strategic Pharma Contracting and Market Access
20d ago
LYFEG
Lyfegen Invests in Product Design to Support Complex Drug Contracting Platform
PremiumPrivate Companies
Lyfegen Invests in Product Design to Support Complex Drug Contracting Platform
20d ago
LYFEG
Lyfegen Adds Product Designer to Strengthen User Experience in Drug Contracting Platform
PremiumPrivate CompaniesLyfegen Adds Product Designer to Strengthen User Experience in Drug Contracting Platform
21d ago
LYFEG
Lyfegen Accelerates AI Drug Contracting Rollout, Expands Talent and Global Market Access Push
Premium
Private Companies
Lyfegen Accelerates AI Drug Contracting Rollout, Expands Talent and Global Market Access Push
23d ago
LYFEG
Lyfegen Targets Complexity in Drug Contracting and Rebate Management
Premium
Private Companies
Lyfegen Targets Complexity in Drug Contracting and Rebate Management
25d ago
LYFEG
Lyfegen Emphasizes Need for Integrated Data in Complex Drug Contracting
PremiumPrivate Companies
Lyfegen Emphasizes Need for Integrated Data in Complex Drug Contracting
26d ago
LYFEG
Lyfegen Highlights Market Access Focus at Canadian Access & Reimbursement Forum
PremiumPrivate Companies
Lyfegen Highlights Market Access Focus at Canadian Access & Reimbursement Forum
26d ago
LYFEG
Follower Milestone Underscores Growing Interest in Lyfegen’s Drug Contracting Focus
PremiumPrivate Companies
Follower Milestone Underscores Growing Interest in Lyfegen’s Drug Contracting Focus
26d ago
LYFEG
Lyfegen Targets Canadian Market Access Opportunities at Toronto Industry Forum
PremiumPrivate Companies
Lyfegen Targets Canadian Market Access Opportunities at Toronto Industry Forum
26d ago
LYFEG
Lyfegen Highlights Growing Community Around Drug Contracting and Market Access
PremiumPrivate CompaniesLyfegen Highlights Growing Community Around Drug Contracting and Market Access
27d ago
LYFEG
Lyfegen Emphasizes MFN Pricing Risks and Demand for Innovative Drug Contracting
Premium
Private Companies
Lyfegen Emphasizes MFN Pricing Risks and Demand for Innovative Drug Contracting
27d ago
LYFEG
Lyfegen Highlights MFN Risks and Push for Innovative Drug Contracting
Premium
Private Companies
Lyfegen Highlights MFN Risks and Push for Innovative Drug Contracting
28d ago
LYFEG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >